Company Inspyr Therapeutics Inc OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 10/10/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Ogilvie
BRD | Director/Board Member | 69 | 31/01/08 |
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Claire Thomas
BRD | Director/Board Member | 68 | 11/10/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,000 | 0 | 0 | 100.00 % |
Stock B | 0 | 5,000 | 0 | 0 | |
Stock C | 0 | 290 | 0 | 0 | |
Stock D | 0 | 71 | 0 | 0 | |
Stock E | 0 | 134 | 0 | 0 | |
Stock F | 1 | 32,132,907 | 32,132,903 ( 100.00 %) | 0 | |
Stock G | 0 | 8,000 | 0 | 0 |
Company contact information
Rebus Holdings, Inc.
2629 Townsgate Road Suite 215
91361, Westlake Village
+818-661-6302
http://www.inspyrtherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- RBSH Stock
- Stock
- Company Inspyr Therapeutics Inc